Clinical care. At-home diagnostics. One app.

eMed is easy to start, & even easier to stick to

A GLP-1 program built to maximize adherence — and bend your healthcare cost curve

24/7 Clinical Support

Personalized Guidance

Continuous Adherence Monitoring

PROVEN OUTCOMES

Industry leading adherence. Real results. Measured from day one

GLP-1 program adherence rate

14.2

Avg. program duration (months)

Reduction in
prediabetes risk

Among members with HbA1C
>5.7% at enrollment*

Drop in high
triglycerides

Among members at >150 mg/dL at enrollment

Reduction in
high cholesterol

Among members at >240 mg/dL at enrollment

-25

lbs

Average weight lost
per member

Starting average:
215 lbs
‍

Matched lab data from a U.S. plan sponsor cohort (N = 382), baseline vs. 6 months. U.S. Plan Sponsor 2025
Source: Aon Workforce-Focused Analysis on GLP-1s, Phase Two Findings; January 13, 2026
*Among matched lab cohort participants with available data, observed reduction in the proportion with HbA1c above 5.7% over the measurement period.Individual results vary. Outcomes are not guaranteed

“High-quality medical care should be accessible to everyone, across different life stages, health goals, and needs.”

Tom Brady

eMed, Chief Wellness Officer

Man with blue eyes and brown hair wearing a navy blue shirt with arms crossed, looking at camera.

You’ve got GLP-1 coverage challenges. eMed has solutions.

From inflated pricing, to access barriers to low adherence and poor outcomes, our program addresses the biggest challenges with GLP-1 coverage.

Two people shaking hands in a bright office setting, with coffee cups and a small cactus on the table.

Lower Cost

Reduce clinical cost of care and get direct pricing on FDA-approved medications with no PBM markups, no rebate inflation and no surprises.

More Control

You set the employee contribution. You manage utilization. You own the outcome.

High Adherence

At-home diagnostics, 24/7 support, and ongoing progress tracking keep members engaged — and on track.

Guaranteed Outcomes

We guarantee employee weight loss and adherence. If we miss, you pay less.

Connect with us

eMed’s unique At Home Screening Kit makes it easy to help the most at-risk members

Most GLP-1 programs simply prescribe medication. eMed built a clinical intake process that creates broader population health intelligence.

Our clinicians screen for key biomarkers and help members get a clearer picture on their health.

HbA1C

Screens for and monitors diabetes; reflects average blood glucose over 2–3 months.

Creatinine

Simple, reproducible, indicator of kidney filtration.

hs-CRP

Biomarker for systemic inflammation in cardiovascular risk assessment.

GGT

Sensitive marker of hepatobiliary dysfunction and oxidative stress.

Lipid Panel

Screens for dyslipidemia; assesses cardiovascular risk via cholesterol levels (TC, LDL, HDL).

Vitamin B12

Screens for megaloblastic anemia and GLP-1 related nutritional deficiencies.

Lipoprotein A

Lp(a) The 2026 ACC/AHA Dyslipidemia Guideline recommends measurement of Lp(a) concentration at least once in all adults for ASCVD risk assessment.

Man with rolled-up sleeve looking at a small blood collection device on his upper arm.

Clinical review may identify risk indicators or findings that warrant follow-up, consistent with applicable clinical protocols. Diagnosis and treatment decisions are made by licensed clinicians and may require referral or follow-up care.

What others are saying about eMed

"When you see the benefits GLP-1 medications bring to the people you work with every day, it underscores how the decisions employers make today shape the future of colleague health, wellbeing and productivity and drive sustainable business performance and growth.”

Lisa Stevens

Chief People and Administrative Officer

Real people. Real results.

Hear directly from eMed members about what it felt like to finally have a program that worked, and what life looks like on the other side.

Our Partners

Whether you're building a
better benefits package or a better you, eMed can help.